A carregar...

Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy

Although endothelin-receptor antagonists reduce albuminuria in diabetic nephropathy, fluid retention limits their use. Here, we examined the effect of atrasentan, a selective endothelin A receptor (ET(A)R) antagonist, on albuminuria in a randomized, double-blind, placebo-controlled trial of subjects...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kohan, Donald E., Pritchett, Yili, Molitch, Mark, Wen, Shihua, Garimella, Tushar, Audhya, Paul, Andress, Dennis L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065231/
https://ncbi.nlm.nih.gov/pubmed/21372210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010080869
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!